Glaucomatous Injury of Central Nerve System

  • Weiwei Chen
  • Shaodan Zhang
  • Ningli WangEmail author
  • Chun Zhang
  • Qing Zhang
  • Jiahe Gan
Part of the Advances in Visual Science and Eye Diseases book series (AVSED, volume 3)


Glaucoma is generally considered to be a disease limited to the eye resulting from characteristic changes to the optic nerve head and corresponding visual field defects caused by elevated intraocular pressure. Therefore, the target of therapies has always been reducing intraocular pressure, supplemented by optic nerve nutritional therapy. Although glaucoma has long been recognized as an optic nerve disease, the study on the glaucomatous pathology merely reached the extracranial segment of the optic nerve, ignoring an important feature of the optic nerve, which constitutes the central nervous system (CNS). Hence, some unexplained problems in clinical practices remained, such as why the visual field impairment and optic nerve damage continue to progress with well-controlled IOP. In this section, the local optic neuropathy caused by glaucoma has been considered as part of disturbance of the whole CNS, and the concept of “integration” is introduced to discuss the characteristics of glaucomatous injury from the entire visual pathway perspective: Glaucoma is a disease impairing the whole visual pathway, which affects not only the optic ganglion cells, but also leads to the destruction of the superior neurons, which might be damaged even earlier than the ganglion cells in glaucoma; the function of not only pathway for form sense but also other sensory pathways would be affected, while the damage by glaucoma may also be associated with the reshape of the structure and function of the cortex. This section enables readers to rediscover the seemingly localized disease, glaucoma, from the integrative perspective of the visual pathway and provides new insights into the diagnosis and treatment of glaucoma in a more comprehensive way.


  1. 1.
    Yucel YH, Zhang Q, Weinreb RN, et al. Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog Retin Eye Res. 2003;22(4):465–81.CrossRefPubMedGoogle Scholar
  2. 2.
    Gupta N, Ly T, Zhang Q, et al. Chronic ocular hypertension induces dendrite pathology in the lateral geniculate nucleus of the brain. Exp Eye Res. 2007;84(1):176–84.CrossRefPubMedGoogle Scholar
  3. 3.
    Sasaoka M, Nakamura K, Shimazawa M, et al. Changes in visual fields and lateral geniculate nucleus in monkey laser-induced high intraocular pressure model. Exp Eye Res. 2008;86(5):770–82.CrossRefPubMedGoogle Scholar
  4. 4.
    Crawford ML, Harwerth RS, Smith EL 3rd, et al. Experimental glaucoma in primates: changes in cytochrome oxidase blobs in V1 cortex. Invest Ophthalmol Vis Sci. 2001;42(2):358–264.PubMedGoogle Scholar
  5. 5.
    Liming T, Nan Z, Xiang Y, et al. Influence of short-term intraocular pressure elevation on receptive field of cat’s dorsal lateral geniculate nucleus. Chin Sci Bull. 2004;49(10):961–4.CrossRefGoogle Scholar
  6. 6.
    Imamura K, Onoe H, Shimazawa M, et al. Molecular imaging reveals unique degenerative changes in experimental glaucoma. Neuroreport. 2009;20(2):139–44.CrossRefPubMedGoogle Scholar
  7. 7.
    Gupta N, Ang LC, Noel de Tilly L, et al. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol. 2006;90(6):674–8.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Hernowo AT, Boucard CC, Jansonius NM, et al. Automated morphometry of the visual pathway in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2011;52(5):2758–66.CrossRefPubMedGoogle Scholar
  9. 9.
    Zhang S, Wang H, Lu Q, et al. Detection of early neuron degeneration and accompanying glial responses in the visual pathway in a rat model of acute intraocular hypertension. Brain Res. 2009;1303:131–43.CrossRefPubMedGoogle Scholar
  10. 10.
    Qing GP, Wang NL. Functional MRI signal changes in primary visual cortex corresponding to the central normal visual field of patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2010;51(9):4627–33.CrossRefPubMedGoogle Scholar
  11. 11.
    Chiquet C, Drouyer E, Woldemussie E, et al. Consequences of glaucoma on circadian and central visual systems. J Fr Ophtalmol. 2006;29(7):847–51.CrossRefPubMedGoogle Scholar
  12. 12.
    Chen Z, Lin F, Wang J, et al. Diffusion tensor magnetic resonance imaging reveals visual pathway damage that correlates with clinical severity in glaucoma. Clin Exp Ophthalmol. 2013;41(1):43–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Chen WW, Wang N, Cai S, et al. Structural brain abnormalities in patients with primary open-angle glaucoma: a study with 3T MR imaging. Invest Ophthalmol Vis Sci. 2013;54(1):545–54.CrossRefPubMedGoogle Scholar
  14. 14.
    Li C, Cai P, Shi L, et al. Voxel-based morphometry of the visual-related cortex in primary open angle glaucoma. Curr Eye Res. 2012;37(9):794–802.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China 2020

Authors and Affiliations

  • Weiwei Chen
    • 1
    • 2
  • Shaodan Zhang
    • 3
  • Ningli Wang
    • 2
    • 4
    Email author
  • Chun Zhang
    • 5
  • Qing Zhang
    • 1
    • 2
  • Jiahe Gan
    • 2
    • 4
  1. 1.Beijing Institute of Ophthalmology, Beijing Tongren HosptialCapital Medical UniversityBeijingChina
  2. 2.Beijing Ophthalmology and Visual Sciences Key LaboratoryBeijingChina
  3. 3.Department of OphthalmologyShenyang fourth People’s HospitalShenyangChina
  4. 4.Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren HosptialCapital Medical UniversityBeijingChina
  5. 5.Department of OphthalmologyPeking University Third HospitalBeijingChina

Personalised recommendations